Nightmare Deconstruction and Reprocessing vs. NightWare Wristband
Key facts
- Who runs it
- Uniformed Services University of the Health Sciences
- Where
- Bethesda, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 2
- People taking part
- 30 people, planned
- Started
- 11 Jun 2024
- Expected to end
- Dec 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Nightmare Deconstruction and Reprocessing
- NightWare
- Record updated
- 1 October 2026
Who can take part
- Age
- 22 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Active duty service members and veterans
- Minimum symptom severity:
- Has had at least 1 nightmare per week for the past month
- Has a minimum ISI score of 8
- If taking medications for PTSD, depression, anxiety, or insomnia, must be on stable dose for 8 weeks
Who cannot take part
- Psychosis, bipolar disorder, or alcohol or substance use disorder
- REM sleep behavior disorder or narcolepsy as determined by investigator
- Serious risk of suicide
- Untreated moderate to severe sleep apnea
- Use of synthetic glucocorticoid beta blockers, prazosin, or varenicline
- Current evidence-based or experimental psychotherapy directly targeting nightmares, insomnia, or PTSD
- Inability to recall nightmare content
- Inability to wear wristband or sync wristband data
- Inability to comply with blood draws
- Refusal to consent to DNA analysis of blood samples
- Refusal to consent to audio recording of study visits
Where in United States
- Uniformed Services University of the Health SciencesBethesda, United States
About the trial
What the trial wants to find out
The overall goal of this Phase IIa randomized controlled pilot trial is to assess the potential efficacy of two emerging treatments for post-trauma nightmares and to test the feasibility of study design and methods. Symptom change will be assessed in two treatment arms: (1) Nightmare Deconstruction and Reprocessing (NDR), an exposure-based psychotherapy; and (2) NightWare (NW), a non-exposure approach using a wristband device. The investigators will also assess the feasibility of circadian-dependent blood sampling and use of another wristband to collect physiologic data. Specific aims are: (1) Compare evidence of how well participants tolerate and comply with the two treatments and test feasibility of methods and procedures; (2) Collect additional evidence of the potential efficacy of two contrasting non-pharmacologic approaches to treating posttraumatic nightmares; (3) Explore the operational stress index (OSI) as a reliable, objective measure of sleep disturbance and nightmare events.
The 2 groups in the trial
- Nightmare Deconstruction and ReprocessingTreatment being tested
Psychotherapy that uses exposure to nightmare images for trauma activation with the goal of memory reconsolidation.
- NightWareTreatment being tested
Wristband device that detects physiologic signals during sleep that indicate a possible nightmare and gently vibrates to rouse the sleeper without fully waking them.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Trial Comparing Exposure and Nonexposure Treatments for Posttrauma Nightmares and Insomnia: Nightmare Deconstruction and Reprocessing vs. NightWare Wristband
- Record updated
- 1 October 2026